KYTX.O (KYTX.O) News
Track canonical SquawkNews coverage tagged to KYTX.O, KYTX.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BRIEF — Kyverna Therapeutics Reports Positive One — Year Data Demonstrating Durable Clinical Responses And Favorable Safety Profile For Miv — Cel In Stiff Person Syndrome And Generalized Myasthenia Gravis
Sept 24 (Reuters) — Kyverna Therapeutics, Inc.: Kyverna Therapeutics Reports Positive One-year Data Demonstrating Durable Clinical Responses And Favorable Safety Profile For Miv-cel In Stiff Person Syndrome And Generaliz
NEWS | Sep 24, 2026, 10:05 AM UTC
L
Kyverna reports positive 1 — year KYSA — 8 trial data for miv — cel in stiff person syndrome
Kyverna reported positive one-year durability data for miv-cel in stiff person syndrome from its KYSA-8 registrational trial. Key trial endpoints were previously presented at AAN 2026; the full one-year dataset will be p
NEWS | Sep 24, 2026, 10:01 AM UTC